Suresh Venkatachari - Healthcare Triangle Pres Chairman
| HCTI Stock | USD 5.11 0.36 7.58% |
Insider
Suresh Venkatachari is Pres Chairman of Healthcare Triangle
| Age | 57 |
| Address | 7901 Stoneridge Drive, Pleasanton, CA, United States, 94588 |
| Phone | 925 270 4812 |
| Web | https://www.healthcaretriangle.com |
Suresh Venkatachari Latest Insider Activity
Tracking and analyzing the buying and selling activities of Suresh Venkatachari against Healthcare Triangle stock is an integral part of due diligence when investing in Healthcare Triangle. Suresh Venkatachari insider activity provides valuable insight into whether Healthcare Triangle is net buyers or sellers over its current business cycle. Note, Healthcare Triangle insiders must abide by specific rules, including filing SEC forms every time they buy or sell Healthcare Triangle'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Suresh Venkatachari over a month ago Acquisition by Suresh Venkatachari of 750000 shares of Healthcare Triangle at 0.001 subject to Rule 16b-3 |
Healthcare Triangle Management Efficiency
The company has return on total asset (ROA) of (0.2972) % which means that it has lost $0.2972 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4399) %, meaning that it created substantial loss on money invested by shareholders. Healthcare Triangle's management efficiency ratios could be used to measure how well Healthcare Triangle manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Healthcare Triangle's Return On Capital Employed is decreasing as compared to previous years. The Healthcare Triangle's current Return On Equity is estimated to increase to 1.23, while Return On Tangible Assets are forecasted to increase to (2.89). As of now, Healthcare Triangle's Non Currrent Assets Other are decreasing as compared to previous years. The Healthcare Triangle's current Debt To Assets is estimated to increase to 1.42, while Total Assets are projected to decrease to under 1.9 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Joshua Wells | Artivion | N/A | |
| Didier Deltort | Zimmer Biomet Holdings | 52 | |
| Katrina Church | Bioventus | 62 | |
| Rachel Ellingson | Zimmer Biomet Holdings | 55 | |
| Matthew Getz | Artivion | 56 | |
| Paul Stellato | Zimmer Biomet Holdings | 50 | |
| Miguel BeltranDelgado | Bioventus | N/A | |
| Dennis Maier | Artivion | 50 | |
| Marna Borgstrom | Artivion | 67 | |
| Wilfred Zuilen | Zimmer Biomet Holdings | 55 | |
| S Mansbach | Avanos Medical | N/A | |
| Rochelle Maney | Artivion | 45 | |
| Thomas Ackerman | Artivion | 66 | |
| F Barthold | Artivion | 56 | |
| John Davis | Artivion | 60 | |
| Kerr Holbrook | Avanos Medical | 58 | |
| Daniel Bevevino | Artivion | 61 | |
| Jean Holloway | Artivion | 63 | |
| Brian Capone | Embecta Corp | 49 | |
| Anthony Semedo | Artivion | 69 | |
| Anthony James | Bioventus | N/A | |
Management Performance
| Return On Equity | -1.44 | ||||
| Return On Asset | -0.3 |
Healthcare Triangle Leadership Team
Elected by the shareholders, the Healthcare Triangle's board of directors comprises two types of representatives: Healthcare Triangle inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthcare. The board's role is to monitor Healthcare Triangle's management team and ensure that shareholders' interests are well served. Healthcare Triangle's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthcare Triangle's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shibu Kizhakevilayil, Head Director | ||
| Suresh Venkatachari, Pres Chairman | ||
| Lakshmanan Kannappan, Head CoFounder | ||
| Sudish Mogli, Consultant | ||
| Chris Paalman, Director Operations | ||
| Abhay Borwankar, Vice Technology | ||
| David Ayanoglou, Chief Officer | ||
| Sujatha Ramesh, Chief Officer | ||
| Anand Kumar, Interim Officer | ||
| Damian David, Senior Development | ||
| Kristi Lane, VP Management | ||
| Thyagarajan Ramachandran, Chief Officer | ||
| Michael Campana, Vice Marketing | ||
| Michael Gill, VP Fin |
Healthcare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthcare Triangle a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.44 | ||||
| Return On Asset | -0.3 | ||||
| Profit Margin | (0.51) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 1.9 B | ||||
| Shares Outstanding | 408.45 M | ||||
| Shares Owned By Insiders | 0.28 % | ||||
| Shares Owned By Institutions | 0.06 % | ||||
| Number Of Shares Shorted | 3.23 M | ||||
| Price To Book | 1,667 X |
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Healthcare Triangle. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Triangle. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (219.12) | Revenue Per Share | Quarterly Revenue Growth (0.1) | Return On Assets | Return On Equity |
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Triangle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.